27 Obesity Statistics by State: 2027 Report

Current data on adult and childhood obesity rates across America, including state rankings, demographic patterns, and what the numbers mean for women considering physician-guided weight management.

Short answer

Alabama has the highest adult obesity rate at 39.7% and Colorado has the lowest among states at 25.7%, based on 2025 data. Twenty-one states had adult obesity prevalence at or above 35%, and the Midwest (35.5%) and South (34.8%) had the highest regional rates.

Majesta HealthReviewed by Ksenia Petrushkina, PA-C
Published Reviewed 13 min read

Current data on adult and childhood obesity rates across America, including state rankings, demographic patterns, and what the numbers mean for women considering physician-guided weight management.

Obesity affects 4 in 10 American adults nationally, but rates vary dramatically depending on where you live. Based on 2025 data, Alabama has the highest reported adult obesity rate at 39.7%, while Colorado has the lowest among states at 25.7%, a gap of 14 percentage points. For women in their 40s to 60s considering physician-guided GLP-1 treatment, understanding these geographic and demographic patterns provides essential context. This statistical report breaks down obesity data by state, region, age, race, and economic factors to help you understand where America stands and what options exist for medically supervised weight management.

Key Takeaways

  • State disparities are substantial: Alabama has the highest adult obesity rate at 39.7%, while Colorado has the lowest among states at 25.7%, based on 2025 data.
  • Middle-aged adults face the highest rates: Adults ages 40–59 have 46.4% obesity prevalence, exceeding all other adult age groups in the 2021–2023 NHANES data.
  • Women experience higher severe obesity rates: 12.1% of women have severe obesity compared to 6.7% of men.
  • Regional patterns are clear: The Midwest leads at 35.5% obesity prevalence, followed by the South at 34.8% in 2025.
  • Obesity remains widespread: 21 states had adult obesity prevalence at or above 35% in 2025.
  • Education correlates with rates: College graduates have 27.8% obesity prevalence compared to 38.1% for those without a high school diploma or equivalent.

National Obesity Prevalence: The Current Picture

1. 40.3% of U.S. adults had obesity during 2021–2023

National Health and Nutrition Examination Survey data shows 40.3% of American adults met obesity criteria during the August 2021 through August 2023 measurement period.

The survey uses measured height and weight to determine body mass index (BMI). Its findings represent adults ages 20 and older across the United States.

This rate, based on clinical measurements, is higher than estimates from surveys that rely on self-reported height and weight. The two methods should not be treated as directly interchangeable.

2. 9.4% of adults have severe obesity

Severe obesity affects 9.4% of American adults, representing the most significant health risk category within obesity classifications.

The CDC defines severe obesity in adults as a BMI of 40 or higher. This estimate comes from the August 2021–August 2023 NHANES measurement period.

Severe obesity is included within overall obesity prevalence, rather than representing a separate population that should be added to the national obesity rate.

3. 21 states had obesity rates at or above 35% in 2025

The number of states with adult obesity rates at or above 35% reached 21 in 2025, compared with 19 states in 2024.

The 2026 State of Obesity report uses CDC Behavioral Risk Factor Surveillance System (BRFSS) data to examine differences between jurisdictions.

By comparison, 23 states exceeded this threshold in 2023. The figures describe the proportion of adults with obesity, not the percentage experiencing severe obesity.

National indicatorReported figureData period
Adult obesity40.3%2021–2023
Severe adult obesity9.4%2021–2023
States with obesity ≥35%212025
States with obesity ≥35%192024

States With the Highest Obesity Rates

4. Alabama: 39.7% (highest in the nation)

Alabama has the highest reported adult obesity rate in America at 39.7%, reflecting ongoing public health challenges in the region.

The figure comes from 2025 BRFSS data and measures the percentage of adults whose self-reported height and weight indicate obesity.

Alabama's rate is higher than the 38.9% reported in the original article using 2024 data. The newer measurement places Alabama first among states with available 2025 figures.

5. North Dakota: 39.1%

North Dakota reports 39.1% adult obesity prevalence in 2025, placing it among the highest-rate states nationally.

This figure appears in the state's public health profile and is based on self-reported adult height and weight.

North Dakota's rate illustrates that elevated adult obesity prevalence is not confined to the Southern states. It also occurs across the northern Great Plains.

6. Kentucky: 38.8%

Kentucky reports 38.8% adult obesity prevalence in 2025, making it one of the three highest-rate states with available data.

This estimate comes from the BRFSS survey and represents adults who meet the BMI-based definition of obesity using self-reported information.

The state's latest reported rate is higher than its 37.2% figure in the original article's 2024 comparison.

7. West Virginia: 37.4%

West Virginia reports an adult obesity rate of 37.4% in 2025, compared with 41.4% in 2024.

The state recorded a statistically significant decline between these reporting years, according to Trust for America's Health.

West Virginia previously had the nation's highest reported rate. Its newer figure should not be presented as the highest in 2025, when Alabama recorded a higher prevalence.

8. Louisiana: 35.6%

Louisiana reports 35.6% obesity prevalence in 2025, compared with 39.2% in 2024.

Like West Virginia, Louisiana experienced a statistically significant decrease in adult obesity prevalence between the two reporting years.

Despite this decline, Louisiana remains above the 35% threshold. The figures refer to the state's adult population rather than children or adolescents.

States With the Lowest Obesity Rates

9. Colorado: 25.7% (lowest among states)

Colorado maintains the lowest reported adult obesity rate among states at 25.7% in 2025, fourteen percentage points below Alabama.

The state's previous 2024 rate was 25.0%, according to its public health data.

Colorado's current figure comes from the same BRFSS surveillance system used for other state comparisons, making its reported prevalence comparable within that dataset.

10. Washington, D.C.: 24.2%

The District of Columbia reports 24.2% obesity prevalence in 2025, lower than every state with available data.

The District is included in national obesity surveillance but is not one of the 50 states.

Its reported rate is below Colorado's 25.7%, making it the lowest-rate jurisdiction identified in the latest comparison.

11. Hawaii: 26.4%

Hawaii's 26.4% adult obesity rate in 2025 places it among the lowest-rate states nationally.

The state previously recorded 27.0% in 2024, according to the preceding State of Obesity report.

Both figures come from self-reported BRFSS measurements. They describe statewide adult obesity prevalence rather than the obesity rate for any particular age or demographic group.

Regional Obesity Patterns

12. Midwest: 35.5% (highest regional rate)

The Midwest leads all regions with 35.5% obesity prevalence in 2025, reflecting elevated rates across several Midwestern states.

The regional estimate comes from the CDC's adult obesity prevalence maps and is based on BRFSS data.

This figure represents the regional adult population rather than an individual state. Regional averages and state-level rankings describe different geographical groupings.

13. South: 34.8%

Southern states collectively report 34.8% obesity prevalence in 2025, including several states with elevated adult obesity rates.

The South ranks second among the four Census regions in the CDC's 2025 obesity surveillance data.

Its prevalence is slightly below the Midwest's 35.5%, even though Alabama has the highest reported individual state rate.

14. West: 30.7%

Western states average 30.7% obesity prevalence in 2025, with Colorado among the states reporting relatively low rates.

This regional figure includes multiple states whose individual obesity prevalence levels differ from one another.

The West's reported prevalence is lower than that of the Midwest and South but remains above the Northeast's corresponding rate.

15. Northeast: 29.6% (lowest regional rate)

The Northeast has the lowest regional obesity rate at 29.6% in the CDC's 2025 estimates.

This figure represents adults living across the Northeastern region, including states with different individual obesity rates.

Although the Northeast ranks lowest among the four regions, its estimate still indicates that obesity affects a substantial share of adults.

U.S. regionAdult obesity rateData year
Midwest35.5%2025
South34.8%2025
West30.7%2025
Northeast29.6%2025

Age-Related Obesity Statistics

16. Adults 40–59: 46.4% obesity prevalence (highest)

Middle-aged adults face the highest obesity rates, with 46.4% prevalence among those ages 40–59 during 2021–2023.

This age group aligns with women often experiencing perimenopause and menopause, when hormonal changes can affect weight and fat distribution.

For those seeking physician evaluation, Majesta Health connects women with independent U.S.-licensed physicians who may prescribe GLP-1 treatment based on individual eligibility.

17. Adults 60 and older: 38.9%

Older adults have 38.9% obesity prevalence, lower than middle-aged adults but still substantial.

The NHANES estimate covers adults ages 60 and older who participated in the August 2021–August 2023 survey.

This measurement is based on clinically measured BMI rather than self-reported height and weight, distinguishing it from the CDC's state-based BRFSS figures.

18. Adults 20–39: 35.5%

Younger adults have 35.5% obesity prevalence, the lowest rate among the adult age groups examined in NHANES.

The estimate applies to adults ages 20–39 during the August 2021–August 2023 measurement period.

The survey found higher prevalence among adults ages 40–59 than among adults ages 20–39, establishing the middle-age peak in this dataset.

Racial and Ethnic Disparities

19. Black adults: 49.9% obesity rate

Black adults have 49.9% obesity prevalence, according to the national demographic findings presented in the 2025 State of Obesity report.

This figure reflects population-level differences in obesity prevalence by race and ethnicity.

These disparities reflect systemic factors including healthcare access, food environment, and socioeconomic conditions rather than biological differences alone. Population averages do not describe an individual's health.

20. Latino/Hispanic adults: 45.6%

Hispanic and Latino adults report 45.6% obesity prevalence, according to the same national demographic analysis.

This is another elevated rate among the racial and ethnic population groups examined in the report.

Race and ethnicity estimates should be interpreted within the definitions and population categories used by the original survey, rather than applied to every community or individual.

Women, Severe Obesity, and Hormonal Considerations

21. 12.1% of women have severe obesity vs. 6.7% of men

Women experience nearly double the severe obesity rate compared to men, with 12.1% of women versus 6.7% of men having a BMI of 40 or higher.

This difference comes from the August 2021–August 2023 NHANES data and is observed across adult age groups.

The gender disparity becomes particularly relevant for women in their 40s to 60s, when perimenopause and menopause can compound weight management challenges. Treatment decisions require individualized physician evaluation.

22. Severe obesity increased from 7.7% to 9.7% over a decade

Age-adjusted severe obesity prevalence rose from 7.7% in 2013–2014 to 9.7% during August 2021–August 2023.

The CDC reports these figures using age-adjusted data to compare obesity prevalence over time.

The 9.7% age-adjusted estimate differs slightly from the 9.4% unadjusted prevalence because the two figures use different statistical calculations.

Education and Socioeconomic Factors

23. College graduates: 27.8% obesity (lowest by education)

Adults with a college degree have 27.8% obesity prevalence, the lowest rate by educational attainment in 2025.

The CDC's estimate is based on self-reported height and weight from BRFSS participants.

Educational attainment is one of several socioeconomic characteristics associated with obesity prevalence. These surveillance statistics describe population groups rather than proving that education determines individual body weight.

24. Without high school diploma: 38.1%

Those without a high school diploma or equivalent face 38.1% obesity prevalence, more than 10 percentage points higher than college graduates.

The CDC reports this percentage using 2025 BRFSS data and its educational attainment categories.

This group is distinct from adults who have completed high school or earned an equivalent qualification, avoiding the category overlap found in other obesity surveys.

Educational attainmentAdult obesity rateData year
Without high school diploma/equivalent38.1%2025
High school diploma/equivalent35.1%2025
Some college36.8%2025
College graduates27.8%2025

Childhood Obesity Statistics

25. 21.1% of youth ages 2–19 have obesity

21.1% of children and adolescents ages 2–19 met obesity criteria during August 2021–August 2023.

The CDC uses age- and sex-specific BMI growth charts to classify childhood obesity, rather than applying adult BMI thresholds.

These estimates are based on measured height and weight from NHANES and describe the overall U.S. youth population.

26. 7.0% of youth have severe obesity

Severe obesity affects 7.0% of U.S. children and adolescents ages 2–19, based on the 2021–2023 NHANES survey.

For children and adolescents, severe obesity is defined using BMI relative to age- and sex-specific growth chart percentiles.

The severe obesity group is included within overall childhood obesity prevalence and is not an additional percentage to add to the 21.1% overall rate.

27. Childhood obesity increased from 13.9% to 21.1%

Childhood obesity prevalence increased from 13.9% to 21.1% between 1999–2000 and August 2021–August 2023.

These national estimates cover children and adolescents ages 2–19 and use the CDC's age- and sex-specific BMI definition.

The figures document a long-term increase in childhood obesity prevalence. They do not indicate that rates tripled during this particular period.

What These Statistics Mean for Weight Management

The data reveals that obesity disproportionately affects adults in midlife, with the 40–59 age group showing the highest prevalence at 46.4% and women experiencing severe obesity at nearly double the rate of men. Geographic location matters significantly, with a 14-percentage-point gap between the highest and lowest states in the latest available comparison.

For women considering medically supervised weight management, telehealth platforms can provide access to physician-guided GLP-1 treatment, subject to state availability. Majesta connects patients with independent U.S.-licensed physicians who evaluate individual eligibility and may prescribe compounded semaglutide or tirzepatide injections when clinically appropriate. Standard eligibility criteria may include BMI ≥30 or BMI ≥27 with a weight-related condition, but final determination requires physician evaluation.

Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication.

For women exploring their options, transparent pricing without hidden fees allows for informed decision-making before beginning any assessment.

How Majesta Supports Informed Weight Management Decisions

Obesity statistics show that weight-related health challenges differ by age, geography, and individual circumstances. For women navigating perimenopause, menopause, or other metabolic changes, these findings provide useful context for discussing appropriate care with a licensed physician.

Majesta offers a women-centered approach to physician-guided weight management through a LegitScript-certified telehealth platform.

Women exploring medically supervised GLP-1 treatment can consider:

  • Individualized physician evaluation: Independent U.S.-licensed physicians review medical history, treatment goals, and contraindications before determining eligibility.
  • Transparent pricing: Essential costs $159 for the first month, then $289/month. Performance costs $269 for the first month, then $399/month, based on company-confirmed November 2026 pricing.
  • Ongoing support: Injection plans include monthly physician check-ins, care-team messaging, and medication and shipping when prescribed.
  • Informed decisions: Treatment suitability depends on individual health needs, clinical assessment, and medication-specific considerations.

Majesta's compounded medications are not FDA-approved final products. Enrollment remained in early access as of November 16, 2026, and Louisiana and Mississippi were listed as waitlist-only.

If you're considering your options, start your assessment to explore the early-access process. Completing an assessment does not guarantee physician approval, treatment, or a prescription.

Before You Consider Weight Management Medication

Discuss your medical history, current medications, pregnancy plans, and possible contraindications with a licensed healthcare professional before considering GLP-1 medication. If you are pregnant, planning pregnancy, or using hormonal contraception, ask about medication-specific precautions.

FDA-approved semaglutide and tirzepatide products carry important warnings and contraindications. The prescribing clinician should review these with you, including a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Other important considerations include pancreatitis, gallbladder problems, and gastrointestinal adverse effects.

Do not independently start, stop, or change medication without guidance from your prescribing clinician.

When to Get Help Right Away

Seek urgent medical attention for severe or persistent abdominal pain, especially when accompanied by vomiting. These symptoms may indicate pancreatitis or another serious medical problem requiring evaluation.

Call 911 for chest pain, difficulty breathing, fainting, or signs of a severe allergic reaction, such as swelling of the face, lips, tongue, or throat.

Contact your prescribing clinician promptly about persistent vomiting, dehydration, severe gastrointestinal symptoms, or other concerning treatment-related effects.

This article is for informational purposes only and does not constitute medical advice, diagnosis or treatment. It does not recommend starting, stopping or changing any medicine.

Sources checked November 20, 2026.

Frequently Asked Questions

How is obesity measured and categorized?

Obesity is typically measured using body mass index (BMI), calculated by dividing weight in kilograms by height in meters squared. The CDC classifies BMI 30–34.9 as Class I obesity, 35–39.9 as Class II obesity, and 40 or higher as Class III (severe) obesity. BMI has limitations, as it does not directly measure body fat or account for muscle mass, bone density, or fat distribution.

Why do obesity rates vary so much between states?

State-level obesity rates reflect complex interactions between socioeconomic factors, food access, physical activity infrastructure, cultural patterns, and healthcare access. States with lower median incomes, fewer walkable communities, and limited access to fresh foods tend to have higher obesity rates. The 14-percentage-point gap between Colorado (25.7%) and Alabama (39.7%) illustrates these disparities in 2025.

What age group has the highest obesity rate?

Adults ages 40–59 have the highest obesity prevalence at 46.4%, exceeding both younger adults (35.5% for ages 20–39) and older adults (38.9% for age 60+). This middle-age peak coincides with metabolic changes, reduced physical activity, and, for women, hormonal shifts related to perimenopause and menopause.

Can telehealth help with physician-guided weight management?

Telehealth platforms can connect patients with licensed physicians who evaluate eligibility for weight management medications, including GLP-1 treatments. This approach may reduce geographic barriers and may be particularly relevant for women in states with limited local options. Treatment requires physician approval based on individual medical history, BMI, contraindications, and health goals.

What are the primary health risks associated with obesity?

Obesity increases the risk of type 2 diabetes, cardiovascular disease, certain cancers, sleep apnea, osteoarthritis, and fatty liver disease. The CDC identifies obesity as a risk factor for multiple chronic conditions that can affect long-term health and quality of life. Individual risk varies with medical history and other health factors.

Sources

  1. 1.Obesity and Severe Obesity Prevalence in Adults: United States, August 2021–August 2023 · CDC, National Center for Health Statistics · accessed
  2. 2.State of Obesity 2026: Better Policies for a Healthier America · Trust for America's Health · accessed
  3. 3.Adult Obesity Prevalence Maps · CDC, Division of Nutrition, Physical Activity, and Obesity · accessed
  4. 4.State of Obesity 2025: Better Policies for a Healthier America · Trust for America's Health · accessed
  5. 5.Prevalence of Overweight, Obesity, and Severe Obesity Among Adults · CDC, National Center for Health Statistics · accessed
  6. 6.Prevalence of Overweight, Obesity, and Severe Obesity Among Children and Adolescents Ages 2–19 Years · CDC, National Center for Health Statistics · accessed
  7. 7.Prevalence of Obesity and Severe Obesity Among Persons Aged 2–19 Years · CDC, Morbidity and Mortality Weekly Report · accessed
  8. 8.Adult Obesity State Profile: Alabama · Trust for America's Health · accessed
  9. 9.Adult Obesity State Profile: North Dakota · Trust for America's Health · accessed
  10. 10.Adult Obesity State Profile: Colorado · Trust for America's Health · accessed
  11. 11.Understanding Adult Overweight and Obesity · National Institute of Diabetes and Digestive and Kidney Diseases · accessed
  12. 12.Consequences of Obesity · Centers for Disease Control and Prevention · accessed
  13. 13.FDA's Concerns With Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration · accessed
  14. 14.Prescription Medications to Treat Overweight and Obesity · National Institute of Diabetes and Digestive and Kidney Diseases · accessed

Ready to Join Early Access?

Join the early access list and we will email you when enrollment opens.

Start Your Assessment